Abstract
Safety and Efficacy of Subcutaneous (SC) Blinatumomab for the Treatment of Adults with Relapsed or Refractory B Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have